4-((2-(2-(3'-fluoro-2'-(methoxycarbonyl)biphenyl-4-yl)ethyl)-5-neopentyl-1H-imidazol-1-yl)methyl)benzoic acid

ID: ALA4593256

Chembl Id: CHEMBL4593256

PubChem CID: 155568881

Max Phase: Preclinical

Molecular Formula: C32H33FN2O4

Molecular Weight: 528.62

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  COC(=O)c1c(F)cccc1-c1ccc(CCc2ncc(CC(C)(C)C)n2Cc2ccc(C(=O)O)cc2)cc1

Standard InChI:  InChI=1S/C32H33FN2O4/c1-32(2,3)18-25-19-34-28(35(25)20-22-10-15-24(16-11-22)30(36)37)17-12-21-8-13-23(14-9-21)26-6-5-7-27(33)29(26)31(38)39-4/h5-11,13-16,19H,12,17-18,20H2,1-4H3,(H,36,37)

Standard InChI Key:  BJZYPBUVSRXPNY-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4593256

    ---

Associated Targets(Human)

BRS3 Tchem Bombesin receptor subtype-3 (700 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Brs3 Bombesin receptor subtype-3 (412 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 528.62Molecular Weight (Monoisotopic): 528.2424AlogP: 6.60#Rotatable Bonds: 9
Polar Surface Area: 81.42Molecular Species: ACIDHBA: 5HBD: 1
#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 4.16CX Basic pKa: 7.23CX LogP: 6.09CX LogD: 5.72
Aromatic Rings: 4Heavy Atoms: 39QED Weighted: 0.25Np Likeness Score: -0.76

References

1. Kiyotsuka Y, Shimada K, Kobayashi S, Suzuki M, Akiu M, Asano M, Sogawa Y, Hara T, Konishi M, Abe-Ohya R, Izumi M, Nagai Y, Yoshida K, Abe Y, Takamori H, Takahashi H..  (2016)  Synthesis and biological evaluation of novel imidazol-1-ylacetic acid derivatives as non-brain penetrant bombesin receptor subtype-3 (BRS-3) agonists.,  26  (17): [PMID:27491709] [10.1016/j.bmcl.2016.07.056]

Source